Qiming U.S. Ventures Management, LLC Portfolio Holdings

Qiming U.S. Ventures Management, LLC

  • $1.66 Million
  • Q4 2024

Qiming U.S. Ventures Management, LLC has filed its 13F form on January 28, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.66 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ventyx Biosciences, Inc. with a value of $902K, Hille Vax, Inc. with a value of $760K, Jasper Therapeutics Inc with a value of $0, Kezar Life Sciences Inc with a value of $0, and Korro Bio Inc with a value of $0.

Examining the 13F form we can see an decrease of $857K in the current position value, from $2.52M to 1.66M.

Below you can find more details about Qiming U.S. Ventures Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.66 Million
Healthcare: $1.66 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$110M
$902,000 54.27% of portfolio
412,225
Q1 2024 Reduced 39.94%
$66.5M
$760,000 45.73% of portfolio
372,615
Q4 2024 Reduced 33.33%

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $1.66 Million
  • Prior Value $2.52 Million
  • Filing
  • Period Q4 2024
  • Filing Date January 28, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Qiming U.S. Ventures Management, LLC Portfolio

Follow Qiming U.S. Ventures Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qiming U.S. Ventures Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Qiming U.S. Ventures Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email